NeuroNanotech is a doctoral network funded by the European Marie Skłodowska-Curie Actions (MSCA) that will train eleven researchers to tackle one of the major challenges in Europe’s ageing population - neurological diseases.
NeuroNanotech brings together experts in nanotechnology, device engineering, neuroscience and clinical neurology. The individual research projects are highly interconnected, ensuring interdisciplinary training.
Researchers will benefit from training in advanced research and relevant complementary skills, imparted by an international and intersectoral consortium of research institutes, universities, companies, hospitals and social organisations from 9 different countries.
The network will provide researchers a unique environment focused on innovation and collaboration, with a view to commercial applications of the research results. This framework will open researchers avenues in both academia and health-related industry.